DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Lovrec P, Bradshaw T, Kyriakopoulos C. et al.
PSMA-based 18F-DCFPyL PET/MRI for Prediction of Progression and Assessment of Response to Neo-Adjuvant Chemohormonal Therapy in Men with High-Risk Primary Prostate Cancer.
J Nucl Med 2021;
2021 (62) 1356
We do not assume any responsibility for the contents of the web pages of other providers.